The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts
- PMID: 9787135
The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts
Abstract
Previously we reported that a karyotypically silent t(4;14)(p16. 3;q32.3) translocation is present in about 25% of multiple myeloma (MM) tumors, and causes overexpression of FGFR3, which is 50 to 100 kb telomeric to the 4p16 breakpoints. Frequent FGFR3 kinase activating mutations in MM with t(4;14) translocations substantiate an oncogenic role for FGFR3. We now report that the 4p16 breakpoints occur telomeric to and within the 5' introns of a novel gene, MMSET (Multiple Myeloma SET domain). In normal tissues, MMSET has a complex pattern of expression with a short form (647 amino acids [aa]) containing an HMG box and hath region, and an alternatively spliced long form (1365 aa) containing the HMG box and hath region plus 4 PHD fingers and a SET domain. Although t(4;14) translocation results in IgH/MMSET hybrid transcripts, overexpression of MMSET also occurs from endogenous promoters on 4p16. Given the homology to HRX/MLL1/ALL1 at 11q23 that is dysregulated by translocations in acute leukemia, we hypothesize that dysregulation of MMSET contributes to neoplastic transformation in MM with t(4;14) translocation. This is the first example of an IgH translocation that simultaneously dysregulates two genes with oncogenic potential: FGFR3 on der(14) and MMSET on der(4).
Copyright 1998 by The American Society of Hematology
Comment in
-
The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance.Blood. 2001 Aug 15;98(4):1271-2. doi: 10.1182/blood.v98.4.1271. Blood. 2001. PMID: 11510469 No abstract available.
Similar articles
-
A molecular study of the t(4;14) in multiple myeloma.Br J Haematol. 2002 Aug;118(2):514-20. doi: 10.1046/j.1365-2141.2002.03618.x. Br J Haematol. 2002. PMID: 12139740
-
Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis.Blood. 2000 Feb 1;95(3):992-8. Blood. 2000. PMID: 10648414
-
A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.Clin Cancer Res. 2004 Sep 1;10(17):5692-701. doi: 10.1158/1078-0432.CCR-04-0467. Clin Cancer Res. 2004. PMID: 15355895
-
MMSET: role and therapeutic opportunities in multiple myeloma.Biomed Res Int. 2014;2014:636514. doi: 10.1155/2014/636514. Epub 2014 Jul 1. Biomed Res Int. 2014. PMID: 25093175 Free PMC article. Review.
-
The enigma of ectopic expression of FGFR3 in multiple myeloma: a critical initiating event or just a target for mutational activation during tumor progression.Curr Opin Hematol. 2002 Jul;9(4):288-93. doi: 10.1097/00062752-200207000-00005. Curr Opin Hematol. 2002. PMID: 12042702 Review.
Cited by
-
Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming.Oncotarget. 2016 Oct 11;7(41):66360-66385. doi: 10.18632/oncotarget.11960. Oncotarget. 2016. PMID: 27626179 Free PMC article.
-
MMSET is the key molecular target in t(4;14) myeloma.Blood Cancer J. 2013 May 3;3(5):e114. doi: 10.1038/bcj.2013.9. Blood Cancer J. 2013. PMID: 23645128 Free PMC article. No abstract available.
-
Understanding the language of Lys36 methylation at histone H3.Nat Rev Mol Cell Biol. 2012 Jan 23;13(2):115-26. doi: 10.1038/nrm3274. Nat Rev Mol Cell Biol. 2012. PMID: 22266761 Free PMC article. Review.
-
Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma.J Hematol Oncol. 2010 Apr 7;3:13. doi: 10.1186/1756-8722-3-13. J Hematol Oncol. 2010. PMID: 20374647 Free PMC article. Review.
-
Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies.Lab Invest. 2018 Dec;98(12):1657-1669. doi: 10.1038/s41374-018-0108-6. Epub 2018 Aug 7. Lab Invest. 2018. PMID: 30087459 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases